Henry Schein, Inc. (NASDAQ:HSIC) is one of the stocks highlighted as Jim Cramer responded to questions from Harvard Business ...

Covetrus Inc., a Portland-based animal health-health company, has sold a Massachusetts-based equine health division to online ...

Henry Schein, Inc. recently reported third quarter 2025 results, showing year-over-year growth in both sales and net income, and raised its full-year 2025 earnings guidance to reflect stronger ...

VideaHealth, the leading dental AI platform, in collaboration with Henry Schein One, today announced the launch of the Impact Panel, a new enhancement within the Detect AI experience for Dentrix (R) ...

All three major U.S. stock indexes slid well into negative territory after the CEOs of Morgan Stanley and Goldman Sachs stoked fears of a potential market bubble, with the S&P 500 having climbed to a ...

Dental supply company Henry Schein recorded $881 million in U.S. dental sales in the third quarter of 2025, according to a Nov. 4 news release from the company.  Here are four additional financial not ...

Shares of Henry Schein Inc. jumped 10.78% to $71.61 Tuesday, on what proved to be an all-around rough trading session for the ...

Henry Schein Inc (HSIC) reports robust global sales growth and strategic advancements, despite facing challenges in operating ...

Q3 2025 Management View Stanley Bergman, Executive Chairman & CEO, reported "sales growth accelerating in each of our ...

Henry Schein tops Q3 earnings and revenue estimates, boosts 2025 outlook, and expands partnership with KKR amid strong dental and tech sales growth.

Henry Schein posted adjusted EPS of $1.38, beating market estimates of $1.28. The company's quarterly sales came in at $3.339 ...

Q3 2025 Earnings Call November 4, 2025 8:00 AM ESTCompany ParticipantsGraham Stanley - VP of Investor Relations & ...